Clinical trial
A Post-Market Observational Clinical Study to Determine the Long-Term Effectiveness and Safety of the Noctrix TOMAC (Tonic Motor Activation) System for the Treatment of Restless Legs Syndrome - The THRIVE Study
NCT06076499 is registered in ClinicalTrials.gov with Noctrix Health, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Post-Market Observational Clinical Study to Determine the Long-Term Effectiveness and Safety of the Noctrix TOMAC (Tonic Motor Activation) System for the Treatment of Restless Legs Syndrome - The THRIVE Study
- Lead sponsor
- Noctrix Health, Inc.
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 15, 2023
- Completion date
- July 31, 2027
- Enrollment
- 325 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.